|

Induction therapy Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • Klinikum Esslingen1
  • Japan Breast Cancer Research Group1
  • Janssen Research & Development, LLC1

Indications

  • Cancer3
  • Metastatic Breast Cancer1
  • Carcinoma, Non-Small-Cell Lung1
  • Multiple Myeloma1
  • Lung Cancer1

Other2 trials

Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC
Phase 2
Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

Tampa, Florida1 trial

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.